Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Altus

This article was originally published in The Tan Sheet

Executive Summary

Quaker Take Heart TV, print ads planned for western New York test marketing of Reducol-containing products, Novartis/Quaker joint venture says Aug. 2. Take Heart cereal available in two flavors at $3.69 for 15 oz. box, six-count snack bars cost $3.19 for all three flavors, two flavors of 48 oz. juice SKUs priced at $2.99. Additional promotions of test launch, begun late June, include Web site, toll-free info line, coupons, health professional outreach. Products will carry FDA-approved health claim for oat fiber and heart health (1"The Tan Sheet" July 9, In Brief)

You may also be interested in...



Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092863

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel